American Vanguard (AVD) 10-Q 3 Nov 15 2015 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Oct. 26, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Trading Symbol	AVD
Entity Registrant Name	AMERICAN VANGUARD CORP
Entity Central Index Key	5,981
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		29,160,234

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Net sales	$ 72,486	$ 71,635	$ 205,574	$ 221,043
Cost of sales	41,053	43,342	124,370	137,785
Gross profit	31,433	28,293	81,204	83,258
Operating expenses	26,059	27,367	74,325	77,903
Operating income	5,374	926	6,879	5,355
Interest expense	700	804	2,090	2,292
Less interest capitalized	(62)	(25)	(149)	(56)
Income before provision for income taxes and (loss) gain on equity investment	4,736	147	4,938	3,119
Income tax expense	1,643	0	958	856
Income before (loss) gain on equity investment	3,093	147	3,980	2,263
Net (loss) gain from equity investment	(389)	461	(580)	321
Net income	2,704	608	3,400	2,584
Add back net loss attributable to non-controlling interest	68	124	204	452
Net income attributable to American Vanguard	2,772	732	3,604	3,036
Change in fair value of interest rate swaps		145		426
Foreign currency translation adjustment	(897)	(491)	(1,468)	(348)
Comprehensive income	$ 1,875	$ 386	$ 2,136	$ 3,114
Earnings per common share-basic	$ 0.10	$ 0.03	$ 0.13	$ 0.11
Earnings per common share-assuming dilution	$ 0.09	$ 0.03	$ 0.12	$ 0.11
Weighted average shares outstanding-basic	28,753	28,466	28,653	28,422
Weighted average shares outstanding-assuming dilution	29,289	28,797	29,208	28,888

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 5,429	$ 4,885
Receivables:
Trade, net of allowance for doubtful accounts of $287 and $166, respectively	89,723	86,027
Other	4,872	2,396
Total receivables	94,595	88,423
Inventories	161,496	165,631
Prepaid expenses	12,135	13,415
Income taxes receivable	1,233	5,964
Deferred income tax assets	8,731	8,731
Total current assets	283,619	287,049
Property, plant and equipment, net	48,460	50,026
Intangible assets, net of applicable amortization	131,006	100,211
Other assets	30,828	35,035
Total assets	493,913	472,321
Current liabilities:
Current installments of long-term debt and other notes payable	10,073	71
Current installments of other liabilities	1,050	1,357
Accounts payable	23,421	20,411
Deferred revenue	38	898
Accrued program costs	73,528	52,546
Accrued expenses and other payables	6,540	5,962
Total current liabilities	114,650	81,245
Long-term debt and other notes payable, excluding current installments	82,658	98,605
Other liabilities, excluding current installments	3,003	3,309
Deferred income tax liabilities	28,159	28,159
Total liabilities	$ 228,470	$ 211,318
Commitments and contingent liabilities
Stockholders' equity:
Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued
Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 31,623,810 shares at September 30, 2015 and 31,550,477 shares at December 31, 2014	$ 3,163	$ 3,156
Additional paid-in capital	68,466	66,232
Accumulated other comprehensive loss	(3,438)	(1,970)
Retained earnings	205,520	202,488
Total stockholders' equity including treasury stock	273,711	269,906
Less treasury stock, at cost, 2,450,634 shares at September 30, 2015 and December 31, 2014	(8,269)	(8,269)
American Vanguard Corporation stockholders' equity	265,442	261,637
Non-controlling interest	1	(634)
Total stockholders' equity	265,443	261,003
Total liabilities and stockholders' equity	$ 493,913	$ 472,321

CONDENSED CONSOLIDATED BALANCE4

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Allowance for doubtful accounts	$ 287	$ 166
Preferred stock, par value per share	$ 0.10	$ 0.10
Preferred stock, shares authorized	400,000	400,000
Preferred stock, shares issued	0	0
Common stock, par value per share	$ 0.10	$ 0.10
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	31,623,810	31,550,477
Treasury stock, shares	2,450,634	2,450,634

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	AVD Total	Non- Controlling Interest
Balance (in shares) at Dec. 31, 2014	31,550,477	31,550,477				2,450,634
Balance at Dec. 31, 2014	$ 261,003	$ 3,156	$ 66,232	$ 202,488	$ (1,970)	$ (8,269)	$ 261,637	$ (634)
Stocks issued under ESPP (in shares)		24,144
Stocks issued under ESPP	280	$ 2	278				280
Cash dividends on common stock ($0.02 per share)	(572)			(572)			(572)
Foreign currency translation adjustment, net	(248)				(248)		(248)
Stock based compensation	1,427		1,427				1,427
Stock options exercised and grants and vesting of restricted stock units (in shares)		11,943
Stock options exercised and grants and vesting of restricted stock units	1,245	$ 1	1,244				1,245
Excess tax benefits from share based payment arrangements	1		1				1
Net income (loss)	(43)			51			51	(94)
Balance (in shares) at Mar. 31, 2015		31,562,678				2,450,634
Balance at Mar. 31, 2015	$ 260,603	$ 3,157	66,694	201,967	(2,218)	$ (8,269)	261,331	(728)
Balance (in shares) at Dec. 31, 2014	31,550,477	31,550,477				2,450,634
Balance at Dec. 31, 2014	$ 261,003	$ 3,156	66,232	202,488	(1,970)	$ (8,269)	261,637	(634)
Foreign currency translation adjustment, net	(1,468)
Net income (loss)	$ 3,400
Balance (in shares) at Sep. 30, 2015	31,623,810	31,623,810				2,450,634
Balance at Sep. 30, 2015	$ 265,443	$ 3,163	68,466	205,520	(3,438)	$ (8,269)	265,442	1
Balance (in shares) at Mar. 31, 2015		31,562,678				2,450,634
Balance at Mar. 31, 2015	260,603	$ 3,157	66,694	201,967	(2,218)	$ (8,269)	261,331	(728)
Stocks issued under ESPP	12		12				12
Foreign currency translation adjustment, net	(323)				(323)		(323)
Stock based compensation	1,058		1,058				1,058
Stock options exercised and grants and vesting of restricted stock units (in shares)		54,604
Stock options exercised and grants and vesting of restricted stock units	937	$ 5	932				937
Adjustment and purchase of non-controlling interest	(125)		(964)				(964)	839
Excess tax benefits from share based payment arrangements	6		6				6
Net income (loss)	739			781			781	(42)
Balance (in shares) at Jun. 30, 2015		31,617,282				2,450,634
Balance at Jun. 30, 2015	262,883	$ 3,162	67,714	202,748	(2,541)	$ (8,269)	262,814	69
Stocks issued under ESPP (in shares)		26,308
Stocks issued under ESPP	305	$ 3	302				305
Foreign currency translation adjustment, net	(897)				(897)		(897)
Stock based compensation	458		458				458
Stock options exercised and grants and vesting of restricted stock units (in shares)		(19,780)
Stock options exercised and grants and vesting of restricted stock units	(11)	$ (2)	(9)				(11)
Excess tax benefits from share based payment arrangements	1		1				1
Net income (loss)	$ 2,704			2,772			2,772	(68)
Balance (in shares) at Sep. 30, 2015	31,623,810	31,623,810				2,450,634
Balance at Sep. 30, 2015	$ 265,443	$ 3,163	$ 68,466	$ 205,520	$ (3,438)	$ (8,269)	$ 265,442	$ 1

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)	3 Months Ended
	Mar. 31, 2015$ / shares
Cash dividends on common stock, per share	$ 0.02

CONDENSED CONSOLIDATED STATEME7

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income (loss)	$ 3,400	$ 2,584
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization of fixed and intangible assets	12,190	11,996
Amortization of other long term assets	3,992	4,332
Amortization of discounted liabilities	118	249
Stock-based compensation	2,943	3,046
Tax benefit from exercise of stock options	(8)	(263)
Operating loss from equity method investment	580	633
Gain from dilution of equity method investment		(954)
Changes in assets and liabilities associated with operations:
Increase in net receivables	(6,172)	(16,995)
Decrease (increase) in inventories	4,135	(31,690)
Decrease (increase) in prepaid expenses and other assets	1,143	(5,237)
Decrease in income tax receivable/payable, net	4,739	7,937
Decrease in deferred tax		(328)
Increase (decrease) in accounts payable	3,010	(22,341)
Decrease in deferred revenue	(860)	(2,769)
Increase in other payables and accrued expenses	22,597	15,964
Net cash provided by (used in) operating activities	51,807	(33,836)
Cash flows from investing activities:
Capital expenditures	(5,196)	(5,947)
Investments	(125)
Acquisitions of product lines and other intangible assets	(36,435)
Net cash used in investing activities	(41,756)	(5,947)
Cash flows from financing activities:
Net (payments) borrowings under line of credit agreement	(16,120)	43,450
Increase in other notes payable	10,000
Payments on other long-term liabilities	(1,252)	(1,371)
Tax benefit from exercise of stock options	8	263
Repurchases of common stock		(1,531)
Non-controlling interest contribution		300
Payment of cash dividends	(1,141)	(4,251)
Net proceeds from the issuance of common stock (sale of stock under ESPP and exercise of stock options)	254	1,616
Net cash (used in) provided by financing activities	(8,251)	38,476
Net increase (decrease) in cash and cash equivalents	1,800	(1,307)
Cash and cash equivalents at beginning of period	4,885	6,680
Effect of exchange rate changes on cash and cash equivalents	(1,256)	(328)
Cash and cash equivalents at end of period	$ 5,429	$ 5,045

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2015
Summary of Significant Accounting Policies	1. The accompanying unaudited condensed consolidated financial statements of American Vanguard Corporation and Subsidiaries (“AVD”) have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015. For further information, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

Property, plant and equipment

Property, plant and equipment	9 Months Ended
	Sep. 30, 2015
Property, plant and equipment	2. Property, plant and equipment at September 30, 2015 and December 31, 2014 consists of the following: September 30, 2015 December 31, 2014 Land $ 2,458 $ 2,458 Buildings and improvements 14,419 14,380 Machinery and equipment 109,223 107,899 Office furniture, fixtures and equipment 4,957 4,698 Automotive equipment 491 374 Construction in progress 6,551 3,432 138,099 133,241 Less accumulated depreciation (89,639 ) (83,215 ) $ 48,460 $ 50,026 During the nine months ended September 30, 2015, the Company eliminated from assets and accumulated depreciation $338 of fully depreciated assets. Substantially all of the Company’s assets are pledged as collateral with its banks.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2015
Inventories	3. Inventories are stated at the lower of cost or market. Cost is determined using the first-in, first-out method. The components of inventories consist of the following: September 30, 2015 December 31, 2014 Finished products $ 128,788 $ 142,853 Raw materials 32,708 22,778 $ 161,496 $ 165,631

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2015
Segment Reporting	4. Based on similar economic and operational characteristics, the Company’s business is aggregated into one reportable segment. Selective enterprise information is as follows: Three Months Ended September 30 Nine Months Ended September 30 2015 2014 2015 2014 Net sales: Insecticides $ 23,539 $ 24,626 $ 85,484 $ 105,587 Herbicides/soil fumigants/fungicides 32,682 29,363 71,973 66,220 Other, including plant growth regulators 7,420 10,711 23,497 23,447 63,641 64,700 180,954 195,254 Non-crop 8,845 6,935 24,620 25,789 $ 72,486 $ 71,635 $ 205,574 $ 221,043 Net sales: US $ 53,167 $ 54,552 $ 146,231 $ 162,602 International 19,319 17,083 59,343 58,441 $ 72,486 $ 71,635 $ 205,574 $ 221,043

Accrued Program Costs

Accrued Program Costs	9 Months Ended
	Sep. 30, 2015
Accrued Program Costs	5. Accrued Program Costs

Cash Dividends

Cash Dividends	9 Months Ended
	Sep. 30, 2015
Cash Dividends	6. The Company declared the following cash dividends in the period covered by this Form 10-Q: Declaration Date Distribution Date Record Date Dividend Per Share Total Paid March 16, 2015 April 17, 2015 April 3, 2015 $ 0.02 $ 572 In addition, the Company paid a dividend of $569 on January 9, 2015 that had been declared on December 11, 2014. As a result, the total amount paid during the nine months ended September 30, 2015 amounted to $1,141. During the nine months ended September 30, 2014, the Company paid dividends of $4,251.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2015
Earnings Per Share	7. ASC 260 Earnings Per Share (“EPS” The components of basic and diluted earnings per share were as follows: Three Months Ended September 30 Nine Months Ended September 30 2015 2014 2015 2014 Numerator: Net income attributable to AVD $ 2,772 $ 732 $ 3,604 $ 3,036 Denominator: Weighted average shares outstanding-basic 28,753 28,466 28,653 28,422 Dilutive effect of stock options and grants 536 331 555 466 29,289 28,797 29,208 28,888 For the three months and nine months ended September 30, 2015, no stock options were excluded from the computation of diluted earnings per share. The Company excluded 1,207 stock options from the computation of diluted earnings per share for the three months ended September 30, 2014 and 6,183 stock options from the computation of diluted earnings per share for the nine months ended September 30, 2014, because they were anti-dilutive.

Indebtedness

Indebtedness	9 Months Ended
	Sep. 30, 2015
Indebtedness	8. The Company has a revolving line of credit and two other notes payable that together constitute the short-term and long-term loan balances shown in the condensed consolidated balance sheets at September 30, 2015 and December 31, 2014. These are summarized in the following table: Indebtedness September 30, 2015 December 31, 2014 $000’s Long- term Short- term Total Long- term Short- term Total Revolving line of credit $ 83,400 $ — $ 83,400 $ 99,400 $ — $ 99,400 Deferred loan fees (742 ) — (742 ) (850 ) — (850 ) Notes payable — 10,073 10,073 55 71 126 Total indebtedness $ 82,658 $ 10,073 $ 92,731 $ 98,605 $ 71 $ 98,676 On June 17, 2013, AMVAC Chemical Corporation (“AMVAC”), the Company’s principal operating subsidiary, as borrower, and affiliates (including the Company), as guarantors and/or borrowers, entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) with a group of commercial lenders led by Bank of the West (AMVAC’s primary bank) as agent, swing line lender and Letter of Credit (“L/C”) issuer. The facility also includes both AMVAC C.V. (“AMVAC CV”) and AMVAC Netherlands B.V. (“AMVAC BV”), both Dutch subsidiaries, as borrowers. The Credit Agreement supersedes the Amended and Restated Credit Agreement dated as of January 10, 2011. The Credit Agreement is a senior secured lending facility with a five year term and consists of a revolving line of credit with a maximum limit of $200 million and an accordion feature with a maximum limit of $100 million. The actual borrowing capacity under this facility depends upon the Company’s compliance with the key covenants described below. In connection with AMVAC’s entering into the Credit Agreement, all outstanding indebtedness under the previously existing credit agreement was rolled over into the Credit Agreement, including the conversion of term loans into revolving debt. On July 18, 2014, AMVAC, as borrower, and affiliates (including the Company), as guarantors and/or borrowers, entered into a First Amendment to Second Amended and Restated Credit Agreement (the “First Amendment”) with a group of commercial lenders led by Bank of the West (AMVAC’s primary bank) as agent, swing line lender and L/C issuer. Under the First Amendment, the Consolidated Funded Debt Ratio was increased for the third and fourth quarters of 2014 and the first quarter of 2015, and, further, borrowers were permitted to pay cash dividends to stockholders during the first and second quarters of 2015 notwithstanding prior net income levels. On April 28, 2015, AMVAC and affiliates (including the Company), as guarantors and/or borrowers, entered into a Second Amendment to Second Amended and Restated Credit Agreement (the “Second Amendment”) with a group of commercial lenders led by Bank of the West (AMVAC’s primary bank) as agent, swing line lender and L/C issuer. Under the Second Amendment, the Consolidated Funded Debt Ratio was increased for the second, third and fourth quarters of 2015. The Company has three key covenants to its senior, secured credit facility with its banking syndicate. The covenants are as follows: (1) the Company must maintain its borrowings below a certain consolidated funded debt ratio (taking into account the Company’s twelve month trailing EBITDA), (2) the Company has a limitation on its annual spending on the acquisition of fixed asset capital additions, and (3) the Company must maintain a certain consolidated fixed charge coverage ratio. As of September 30, 2015 the Company met all covenants in that credit facility. At September 30, 2015, based on its performance against the most restrictive covenants listed above, the Company had the capacity to increase its borrowings by up to $40,189 under the credit facility agreement. This compares to an available borrowing capacity of $51,156 as of September 30, 2014. The level of borrowing capacity is driven by three factors: (1) our financial performance, as measured in EBITDA for trailing twelve month period, has improved, (2) borrowings have decreased notwithstanding the product line acquisitions completed in the second quarter of 2015 and (3) the leverage covenant (being the number of times EBITDA the Company may borrow under its credit facility agreement) is lower when compared with the earlier period. During the three month and nine month periods ended September 30, 2014 (and throughout the balance of 2014, terminating on December 31, 2014), the Company had in place one interest rate swap contract. While in place, the interest rate swap contract was accounted for under FASB ASC 815 as a cash flow hedge. The effective portion of the gains or losses on the interest rate swap were reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transactions affected earnings. As a result of the termination of the swap contract, there were no gains or losses in other comprehensive income (“OCI”) related to interest rate swap contracts that were expected to be reclassified to earnings in the coming 12 months. The following tables illustrate the impact of derivatives on the Company’s statements of operations and comprehensive income for the three months and nine months ended September 30, 2015 and 2014. The Effect of Derivative Instruments on the Statement of Financial Performance For the three months ended September 30, 2015 and 2014 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Location of Gain or (Loss) Reclassified from Accumulated Amount of Gain or (Loss) OCI into Income (Effective Portion) Location of Gain or (Loss) Recognized in Amount of Gain or (Loss) Recognized in Income on (Ineffective Portion) Derivatives in ASC 815 Cash Flow Hedging Relationships 2015 2014 OCI into Income (Effective Portion) 2015 2014 Income on Derivative (Ineffective Portion) 2015 2014 Interest rate contracts $ — $ (1 ) Interest Expense $ — $ (146 ) Interest Expense $ — $ — Total $ — $ (1 ) $ — $ (146 ) $ — $ — For the nine months ended September 30, 2015 and 2014 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Location of Gain or (Loss) Reclassified from Accumulated Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Location of Gain or (Loss) Recognized in Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion) Derivatives in ASC 815 Cash Flow Hedging Relationships 2015 2014 OCI into Income (Effective Portion) 2015 2014 Income on Derivative (Ineffective Portion) 2015 2014 Interest rate contracts $ — $ (32 ) Interest Expense $ — $ (459 ) Interest Expense $ — $ — Total $ — $ (32 ) $ — $ (459 ) $ — $ —

Reclassification

Reclassification	9 Months Ended
	Sep. 30, 2015
Reclassification	9. Reclassification—Certain items have been reclassified in the prior period condensed consolidated financial statements to conform with the September 30, 2015 presentation.

Comprehensive (Loss) Income

Comprehensive (Loss) Income	9 Months Ended
	Sep. 30, 2015
Comprehensive (Loss) Income	10. Total comprehensive income includes, in addition to net income, changes in equity that are excluded from the condensed consolidated statements of operations and are recorded directly into a separate section of stockholders’ equity on the condensed consolidated balance sheets. For the three month and nine month periods ended September 30, 2015, total comprehensive income consisted of net income attributable to American Vanguard and foreign currency translation adjustments.

Stock Based Compensation

Stock Based Compensation	9 Months Ended
	Sep. 30, 2015
Stock Based Compensation	11. Stock Based Compensation—The Company accounts for stock-based awards to employees and directors in accordance with FASB ASC 718, “ Share-Based Payment The below tables illustrate the Company’s stock based compensation, unamortized stock-based compensation, and remaining weighted average period for the three months and nine months ended September 30, 2015 and 2014. Stock-Based Compensation for the Three months ended Stock-Based Compensation for the Nine months ended Unamortized Stock-Based Compensation Remaining Weighted Average Period (years) September 30, 2015 Incentive Stock Options $ 94 $ 325 $ 1,009 2.3 Restricted Stock 334 2,296 2,751 1.5 Performance Based Restricted Stock 18 222 686 1.8 Performance Based Options 12 100 373 2.2 Total $ 458 $ 2,943 $ 4,819 September 30, 2014 Incentive Stock Options $ — $ 21 $ — — Restricted Stock 1,139 2,958 6,069 1.9 Performance Based Restricted Stock 101 67 1,404 2.4 Total $ 1,240 $ 3,046 $ 7,473 Stock Options—During the nine months ended September 30, 2015, the Company did not grant any employees options to acquire shares of common stock. Option activity within each plan is as follows: Incentive Stock Option Plans Weighted Average Price Per Share Exercisable Weighted Average Price Per Share Balance outstanding, December 31, 2014 724,904 $ 9.22 $ 7.82 Options exercised, $7.50 (16,650 ) 7.50 Options forfeited, $11.49 and $13.24 (10,400 ) 11.49 Balance outstanding, March 31, 2015 697,854 $ 9.21 $ 7.71 Options exercised, $7.50 (34,800 ) 7.50 Options forfeited, $11.49 (2,481 ) 11.49 Balance outstanding, June 30, 2015 660,573 $ 9.29 $ 7.72 Options exercised, $7.50 (4,000 ) 7.50 Options forfeited, $11.49 (22,582 ) 11.49 Balance outstanding, September 30, 2015 633,991 $ 9.25 $ 7.73 Information relating to stock options at September 30, 2015 summarized by exercise price is as follows: Outstanding Weighted Average Exercisable Weighted Average Exercise Price Per Share Shares Remaining Life (Months) Exercise Price Shares Exercise Price Incentive Stock Option Plan: $7.50 361,750 62 $ 7.50 361,750 $ 7.50 $11.32—$11.49 272,241 107 $ 11.56 16,679 $ 12.69 633,991 $ 9.25 378,429 $ 7.73 The weighted average exercise prices for options granted and exercisable and the weighted average remaining contractual life for options outstanding as of September 30, 2015 was as follows: Number of Shares Weighted Average Exercise Price Weighted Average Intrinsic As of September 30, 2015: Incentive Stock Option Plans: Outstanding 633,991 $ 9.25 82 $ 1,489 Expected to Vest 623,148 $ 9.21 81 $ 1,488 Exercisable 378,429 $ 7.73 62 $ 1,471 During the three months ended September 30, 2015 and 2014, the Company recognized stock-based compensation related to stock options of $94 and $0, respectively. During the nine months ended September 30, 2015 and 2014, the Company recognized stock-based compensation related to stock options of $325 and $21, respectively. As of September 30, 2015, the Company had approximately $1,009 of unamortized stock-based compensation related to unvested stock options outstanding. This amount will be recognized over the weighted-average period of 2.3 years. This projected expense will change if any stock options are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures. Restricted Shares — Nine Months Ended September 30, 2015 Nine Months Ended September 30, 2014 Number Weighted Number Weighted Nonvested shares at January 1 st 560,842 $ 21.44 376,702 $ 24.85 Granted 30,000 11.42 — — Vested (192,266 ) 20.47 (1,000 ) 31.83 Forfeited (422 ) 14.92 (1,840 ) 24.23 Nonvested shares at March 31 st 398,154 $ 21.17 373,862 $ 24.83 Granted 21,005 14.28 240,724 14.81 Vested (28,505 ) 13.53 (23,478 ) 13.84 Forfeited (1,201 ) 14.92 — — Nonvested shares at June 30 th 389,453 $ 21.37 591,108 $ 21.19 Granted 13,196 12.88 — — Vested (19,000 ) 27.93 (4,000 ) 12.16 Forfeited (26,723 ) 22.64 (6,104 ) 14.92 Nonvested shares at September 30 th 356,926 $ 20.62 581,004 $ 21.32 Restricted stock grants — During the nine months ended September 30, 2015, the Company granted a total of 64,201 shares of common stock. Of these, 21,005 shares vest immediately, 7,500 shares will vest after 90 days from date of grant, 3,196 shares will vest one-third each year on the anniversaries of the employee’s employment date and the balance will cliff vest after three years of service. The shares granted in 2015 were average fair valued at $12.66 per share. The fair value was determined by using the publicly traded share price as of the date of grant. The Company is recognizing as expense the value of restricted shares over the required service period. During the nine months ended September 30, 2014, the Company granted a total of 240,724 shares of common stock. Of these, 23,478 shares vest immediately, and the balance will cliff vest after three years of service. The shares granted in 2014 were average fair valued at $14.81 per share. The fair value was determined by using the publicly traded share price as of the date of grant. The Company is recognizing as expense the value of restricted shares over the required service period. During the three months ended September 30, 2015 and 2014, the Company recognized stock-based compensation related to restricted shares of $334 and $1,139, respectively. During the nine months ended September 30, 2015 and 2014, the Company recognized stock-based compensation related to restricted shares of $2,296 and $2,958, respectively. As of September 30, 2015 and 2014, the Company had approximately $2,751 and $6,069, respectively, of unamortized stock-based compensation related to unvested restricted shares. This amount will be recognized over the weighted-average period of 1.5 and 1.9 years, respectively. This projected expense will change if any restricted shares are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures. Performance Based Shares — Nine Months Ended September 30, 2015 Nine Months Ended September 30, 2014 Number Weighted Number Weighted Date Fair Nonvested shares at January 1 st 103,907 $ 17.77 24,637 $ 28.28 Granted 7,500 10.96 — — Nonvested shares at March 31 st 111,407 $ 17.31 24,637 $ 28.28 Granted — — 79,270 14.51 Nonvested shares at June 30 th 111,407 $ 17.31 103,907 $ 17.77 Granted 3,196 12.37 — — Forfeited (10,200 ) 18.43 — — Nonvested shares at September 30 th 104,403 $ 17.05 103,907 $ 17.77 Performance Based Shares — During the nine months ended September 30, 2015, the Company granted a total of 10,696 performance based shares. Of these, 7,500 shares will cliff vest on January 5, 2018 with a measurement period commencing January 1, 2015 and ending December 31, 2017 and 3,196 shares will cliff vest on August 1, 2018 with a measurement period commencing July 1, 2015 and ending June 30, 2018, provided that the recipient is continuously employed by the Company during the vesting period. Eighty percent of these performance based shares are based upon financial performance of the Company, specifically, an earnings before income tax (“EBIT”) goal weighted at 50% and a net sales goal weighted at 30%. The remaining 20% of performance based shares are based upon AVD stock price appreciation over the same performance measurement period. The EBIT and net sales goals measure the relative growth of the Company’s EBIT and net sales for the performance measurement period, as compared to the median growth of EBIT and net sales for an identified peer group. The stockholder return goal measures the relative growth of the fair market value of the Company’s stock price over the performance measurement period, as compared to that of the Russell 2000 Index and the median fair market value of the common stock of the comparator companies, identified in the Company’s 2015 Proxy Statement. All parts of these awards vest in three years, but are subject to reduction to a minimum (or even zero) for meeting less than the targeted performance and to increase to a maximum of 200% for meeting in excess of the targeted performance. During the nine months ended September 30, 2014, the Company granted a total of 79,270 performance based shares that will cliff vest on May 23, 2017, provided that recipient is continuously employed by the Company during the vesting period. Of these performance based shares, 80% are based upon financial performance of the Company, specifically, an earnings before interest and tax (“EBIT”) goal weighted at 50% and a net sales goal weighted at 30% for the period commencing April 1, 2014 and ending December 31, 2016; the remaining 20% of performance based shares are based upon AVD stock price appreciation (shareholder return) over the same performance measurement period. The net sales and EBIT goal measures the relative growth of the Company’s net sales and EBIT for the performance measurement period, as compared to the median growth of net sales and EBIT for an identified peer group. The stockholder return goal measures the relative growth of the fair market value of the Company’s stock price over the performance measurement period, as compared to that of the Russell 2000 Index and the median fair market value of the common stock of the comparator companies. All parts of these awards vest in three years, but are subject to reduction to a minimum (or even zero) for meeting less than the targeted performance and to increase to a maximum of 200% for meeting in excess of the targeted performance. As of September 30, 2015, performance based shares related to net income and net sales have an average fair value of $11.86 per share. The fair value was determined by using the publicly traded share price as of the date of grant. The performance based shares related to the Company’s stock price have an average fair value of $9.48 per share. The fair value was determined by using the Monte Carlo valuation method. For awards with performance conditions, the Company recognizes share-based compensation cost on a straight-line basis for each performance criteria over the implied service period. During the three months ended September 30, 2015 and 2014, the Company recognized stock-based compensation related to performance based shares of $18 and $101, respectively. During the nine months ended September 30, 2015, the Company recognized stock-based compensation related to performance based shares of $222. During the nine months ended September 30, 2014, the Company recognized stock-based compensation related to performance based shares of $67. As of September 30, 2015, the Company had approximately $686 of unamortized stock-based compensation related to unvested performance based shares. This amount will be recognized over the weighted-average period of 1.8 years. This projected expense will change if any performance based shares are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures. Performance Incentive Stock Options—During the nine months ended September 30, 2015 and 2014, the Company did not grant any employees performance incentive stock options to acquire shares of common stock. Performance option activity is as follows: Incentive Weighted Average Exercisable Balance outstanding, December 31, 2014 107,689 $ 11.49 $ — Options forfeited, $11.49 (9,279 ) 11.49 Balance outstanding, September 30, 2015 98,410 $ 11.49 $ — Information relating to outstanding stock options at September 30, 2015 summarized by exercise price is as follows: Outstanding Weighted Average Exercisable Weighted Exercise Price Per Share Shares Remaining Exercise Shares Exercise Performance Incentive Stock Option Plan: $11.49 98,410 27 $ 11.49 — $ — 98,410 $ 11.49 — $ — The weighted average exercise prices for options granted and exercisable and the weighted average remaining contractual life for options outstanding as of September 30, 2015 are as follows: Number Weighted Weighted Intrinsic As of September 30, 2015: Incentive Stock Option Plans: Outstanding 98,410 $ 11.49 27 $ 7 Expected to Vest 54,692 $ 11.49 27 $ 4 Exercisable — $ — — $ — During the three months ended September 30, 2015 the Company recognized stock-based compensation related to performance stock options of $12. There were no performance incentive stock options issued by the Company prior to those issued during the quarter ended December 31, 2014. During the nine months ended September 30, 2015 the Company recognized stock-based compensation related to performance stock options of $100. There were no performance incentive stock options issued by the Company prior to those issued during the quarter ended December 31, 2014. As of September 30, 2015, the Company had approximately $373 of unamortized stock-based compensation related to unvested performance incentive stock options outstanding. This amount will be recognized over the weighted-average period of 2.2 years. This projected expense will change if any performance incentive stock options are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures.

Legal Proceedings

Legal Proceedings	9 Months Ended
	Sep. 30, 2015
Legal Proceedings	12. Legal Proceedings—During the reporting period, there have been no material developments in the legal proceedings that were reported in the Company’s Form 10-K for the period ended December 31, 2014, other than as discussed below: A. DBCP Cases On or about May 31, 2012, HendlerLaw, P.C., which represents plaintiffs in seven related matters that had been pending before the United States District Court for the Eastern District of Louisiana (the “Hendler – Louisiana Cases” referred to in the Company’s Form 10-K for the period ended December 31, 2011 as Aguilar et al., v. Dole Fruit Company, Inc., et al Chaverri et al. v. Dole Food Company, Inc. et al Chaverri In October 2012, the federal district court in Louisiana granted defendant’s motion for summary judgment and dismissed the Hendler – Louisiana Cases for plaintiffs’ failure to bring the action within the applicable statute of limitations. Plaintiffs appealed the dismissal of the Hendler – Louisiana cases and, on September 19, 2013, the Fifth Circuit Court of Appeal upheld the lower court’s decision, finding no reason to reverse the dismissal. On October 16, 2013, Plaintiffs filed a notice of appeal in the Hendler – Delaware cases. Oral argument was heard before the Third Circuit Court of Appeal on June 24, 2014 in connection with that appeal, and, on August 11, 2015, the Third Circuit upheld the lower court’s dismissal of the Hendler – Delaware cases. However, plaintiffs petitioned for rehearing en banc, arguing that, despite the fact that the same plaintiffs had made the same claims before another court (namely, the Louisiana court in the Hendler – Louisiana cases), because the Louisiana court had not decided the case on the merits (but, rather, on the basis of the statute of limitations), the Delaware trial court lacked the power to dismiss the Hendler – Delaware cases with prejudice. On September 22, 2015, the Third Circuit vacated its previous ruling (to uphold the lower court dismissal) and set the appeal for rehearing en banc on February 17, 2016. Thus, the appeal of the dismissal of the Hendler – Delaware cases will be reheard by the Third Circuit. The Company believes the Hendler – Delaware cases have no merit and, further, that a loss is neither probable nor reasonably estimable; accordingly, it has not recorded a loss contingency. B. Other Matters Sanchez v. Agro Logistics Sanchez v. Agro Logistic Systems, Inc. et al USEPA TSCA Matter

Recently Issued Accounting Guid

Recently Issued Accounting Guidance	9 Months Ended
	Sep. 30, 2015
Recently Issued Accounting Guidance	13. Recently Issued Accounting Guidance— In September 2015, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-16, Business Combination (Topic 805):Simplifying the Accounting for Measurement Period Adjustments. In July 2015, FASB issued ASU2015-11, Inventory (Topic 330) In April 2015, FASB issued ASU 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. In August 2014, FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In June 2014, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-12, Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period, a consensus of the FASB Emerging Issues Task Force In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2015
Fair Value of Financial Instruments	14. Fair Value of Financial Instruments—The carrying values of cash, receivables and accounts payable approximate their fair values because of the short maturity of these instruments. The fair value of the Company’s long-term debt and note payable to bank is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to the Company for debt of the same remaining maturities. Such fair value approximates the respective carrying values of the Company’s long-term debt and note payable to bank.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income ("AOCI")	9 Months Ended
	Sep. 30, 2015
Accumulated Other Comprehensive Income ("AOCI")	15. Accumulated Other Comprehensive Income (“AOCI”) — Balance, December 31, 2014 $ (1,970 ) Other comprehensive loss (248 ) Balance, March 31, 2015 $ (2,218 ) Other comprehensive loss (323 ) Balance, June 30, 2015 $ (2,541 ) Other comprehensive loss (897 ) Balance, September 30, 2015 $ (3,438 )

Equity Investment

Equity Investment	9 Months Ended
	Sep. 30, 2015
Equity Investment	16. On March 25, 2013, the Company made a $3,687 equity investment in TyraTech Inc. (“TyraTech”), a Delaware corporation that specializes in developing, marketing and selling pesticide products containing essential oils and other natural ingredients, to acquire an ownership position of approximately 29.27%. During 2014 TyraTech completed two separate funding transactions. In February 2014, TyraTech issued 37,391,763 shares and raised approximately £1,870 ($3,100) and then in July 2014, TyraTech issued a further 50,000,000 shares and raised approximately £3,500 ($5,900). Due to these share issuances, the Company recognized a total gain of $954 from the dilution of the Company’s ownership position. In October 2014, the Company exercised warrants in the amount of $500 and purchased 6,155,000 shares in TyraTech. As a result of the share issuances and the exercise of warrants, the Company’s ownership position in TyraTech was approximately 21.18% as of September 30, 2015. The Company utilizes the equity method of accounting with respect to this investment. As a result, our net income includes losses from equity method investments, which represents our proportionate share of TyraTech’s estimated net losses for the current accounting period. The Company recognized a loss of $389 and $580 for the three months and nine months ended September 30, 2015, respectively, as a result of the Company’s ownership position in TyraTech. The Company’s investment in TyraTech is included in other assets on the condensed consolidated balance sheet. At September 30, 2015, the carrying value of the Company’s investment in TyraTech was $2,592 and the quoted market value of its shareholding was $3,999 based on the London Stock Exchange, Alternative Investment Market (“AIM”).

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2015
Income Taxes	17. Income Taxes —

Product Acquisitions

Product Acquisitions	9 Months Ended
	Sep. 30, 2015
Product Acquisitions	18. Product Acquisitions —

Property, plant and equipment (

Property, plant and equipment (Tables)	9 Months Ended
	Sep. 30, 2015
Summary of Property, Plant and Equipment	Property, plant and equipment at September 30, 2015 and December 31, 2014 consists of the following: September 30, 2015 December 31, 2014 Land $ 2,458 $ 2,458 Buildings and improvements 14,419 14,380 Machinery and equipment 109,223 107,899 Office furniture, fixtures and equipment 4,957 4,698 Automotive equipment 491 374 Construction in progress 6,551 3,432 138,099 133,241 Less accumulated depreciation (89,639 ) (83,215 ) $ 48,460 $ 50,026

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2015
Components of Inventories	The components of inventories consist of the following: September 30, 2015 December 31, 2014 Finished products $ 128,788 $ 142,853 Raw materials 32,708 22,778 $ 161,496 $ 165,631

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2015
Summary of Business Sales Segmentation as per Product	Selective enterprise information is as follows: Three Months Ended September 30 Nine Months Ended September 30 2015 2014 2015 2014 Net sales: Insecticides $ 23,539 $ 24,626 $ 85,484 $ 105,587 Herbicides/soil fumigants/fungicides 32,682 29,363 71,973 66,220 Other, including plant growth regulators 7,420 10,711 23,497 23,447 63,641 64,700 180,954 195,254 Non-crop 8,845 6,935 24,620 25,789 $ 72,486 $ 71,635 $ 205,574 $ 221,043
Summary of Business Sales Segmentation as per Location	Three Months Ended September 30 Nine Months Ended September 30 2015 2014 2015 2014 Net sales: Insecticides $ 23,539 $ 24,626 $ 85,484 $ 105,587 Herbicides/soil fumigants/fungicides 32,682 29,363 71,973 66,220 Other, including plant growth regulators 7,420 10,711 23,497 23,447 63,641 64,700 180,954 195,254 Non-crop 8,845 6,935 24,620 25,789 $ 72,486 $ 71,635 $ 205,574 $ 221,043 Net sales: US $ 53,167 $ 54,552 $ 146,231 $ 162,602 International 19,319 17,083 59,343 58,441 $ 72,486 $ 71,635 $ 205,574 $ 221,043

Cash Dividends (Tables)

Cash Dividends (Tables)	9 Months Ended
	Sep. 30, 2015
Cash Dividends	The Company declared the following cash dividends in the period covered by this Form 10-Q: Declaration Date Distribution Date Record Date Dividend Per Share Total Paid March 16, 2015 April 17, 2015 April 3, 2015 $ 0.02 $ 572

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2015
Components of Basic and Diluted Earnings Per Share	The components of basic and diluted earnings per share were as follows: Three Months Ended September 30 Nine Months Ended September 30 2015 2014 2015 2014 Numerator: Net income attributable to AVD $ 2,772 $ 732 $ 3,604 $ 3,036 Denominator: Weighted average shares outstanding-basic 28,753 28,466 28,653 28,422 Dilutive effect of stock options and grants 536 331 555 466 29,289 28,797 29,208 28,888

Indebtedness (Tables)

Indebtedness (Tables)	9 Months Ended
	Sep. 30, 2015
Summary of Short-Term and Long-Term Loan Balances in Condensed Consolidated Balance Sheets	The Company has a revolving line of credit and two other notes payable that together constitute the short-term and long-term loan balances shown in the condensed consolidated balance sheets at September 30, 2015 and December 31, 2014. These are summarized in the following table: Indebtedness September 30, 2015 December 31, 2014 $000’s Long- term Short- term Total Long- term Short- term Total Revolving line of credit $ 83,400 $ — $ 83,400 $ 99,400 $ — $ 99,400 Deferred loan fees (742 ) — (742 ) (850 ) — (850 ) Notes payable — 10,073 10,073 55 71 126 Total indebtedness $ 82,658 $ 10,073 $ 92,731 $ 98,605 $ 71 $ 98,676
Summary of Effect of Derivative Instruments on Statements of Operations and Comprehensive Income	The following tables illustrate the impact of derivatives on the Company’s statements of operations and comprehensive income for the three months and nine months ended September 30, 2015 and 2014. The Effect of Derivative Instruments on the Statement of Financial Performance For the three months ended September 30, 2015 and 2014 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Location of Gain or (Loss) Reclassified from Accumulated Amount of Gain or (Loss) OCI into Income (Effective Portion) Location of Gain or (Loss) Recognized in Amount of Gain or (Loss) Recognized in Income on (Ineffective Portion) Derivatives in ASC 815 Cash Flow Hedging Relationships 2015 2014 OCI into Income (Effective Portion) 2015 2014 Income on Derivative (Ineffective Portion) 2015 2014 Interest rate contracts $ — $ (1 ) Interest Expense $ — $ (146 ) Interest Expense $ — $ — Total $ — $ (1 ) $ — $ (146 ) $ — $ — For the nine months ended September 30, 2015 and 2014 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Location of Gain or (Loss) Reclassified from Accumulated Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Location of Gain or (Loss) Recognized in Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion) Derivatives in ASC 815 Cash Flow Hedging Relationships 2015 2014 OCI into Income (Effective Portion) 2015 2014 Income on Derivative (Ineffective Portion) 2015 2014 Interest rate contracts $ — $ (32 ) Interest Expense $ — $ (459 ) Interest Expense $ — $ — Total $ — $ (32 ) $ — $ (459 ) $ — $ —

Stock Based Compensation (Table

Stock Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2015
Stock Based Compensation, Unamortized Stock-Based Compensation and Remaining Weighted Average Period	The below tables illustrate the Company’s stock based compensation, unamortized stock-based compensation, and remaining weighted average period for the three months and nine months ended September 30, 2015 and 2014. Stock-Based Compensation for the Three months ended Stock-Based Compensation for the Nine months ended Unamortized Stock-Based Compensation Remaining Weighted Average Period (years) September 30, 2015 Incentive Stock Options $ 94 $ 325 $ 1,009 2.3 Restricted Stock 334 2,296 2,751 1.5 Performance Based Restricted Stock 18 222 686 1.8 Performance Based Options 12 100 373 2.2 Total $ 458 $ 2,943 $ 4,819 September 30, 2014 Incentive Stock Options $ — $ 21 $ — — Restricted Stock 1,139 2,958 6,069 1.9 Performance Based Restricted Stock 101 67 1,404 2.4 Total $ 1,240 $ 3,046 $ 7,473
Summary of Option Activity	Option activity within each plan is as follows: Incentive Stock Option Plans Weighted Average Price Per Share Exercisable Weighted Average Price Per Share Balance outstanding, December 31, 2014 724,904 $ 9.22 $ 7.82 Options exercised, $7.50 (16,650 ) 7.50 Options forfeited, $11.49 and $13.24 (10,400 ) 11.49 Balance outstanding, March 31, 2015 697,854 $ 9.21 $ 7.71 Options exercised, $7.50 (34,800 ) 7.50 Options forfeited, $11.49 (2,481 ) 11.49 Balance outstanding, June 30, 2015 660,573 $ 9.29 $ 7.72 Options exercised, $7.50 (4,000 ) 7.50 Options forfeited, $11.49 (22,582 ) 11.49 Balance outstanding, September 30, 2015 633,991 $ 9.25 $ 7.73
Summary of Stock Options Summarized by Exercise Price	Information relating to stock options at September 30, 2015 summarized by exercise price is as follows: Outstanding Weighted Average Exercisable Weighted Average Exercise Price Per Share Shares Remaining Life (Months) Exercise Price Shares Exercise Price Incentive Stock Option Plan: $7.50 361,750 62 $ 7.50 361,750 $ 7.50 $11.32—$11.49 272,241 107 $ 11.56 16,679 $ 12.69 633,991 $ 9.25 378,429 $ 7.73
Weighted Average Exercise Prices for Options Granted and Exercisable and Weighted Average Remaining Contractual Life for Options Outstanding	The weighted average exercise prices for options granted and exercisable and the weighted average remaining contractual life for options outstanding as of September 30, 2015 was as follows: Number of Shares Weighted Average Exercise Price Weighted Average Intrinsic As of September 30, 2015: Incentive Stock Option Plans: Outstanding 633,991 $ 9.25 82 $ 1,489 Expected to Vest 623,148 $ 9.21 81 $ 1,488 Exercisable 378,429 $ 7.73 62 $ 1,471
Performance Based Options
Summary of Option Activity	Performance option activity is as follows: Incentive Weighted Average Exercisable Balance outstanding, December 31, 2014 107,689 $ 11.49 $ — Options forfeited, $11.49 (9,279 ) 11.49 Balance outstanding, September 30, 2015 98,410 $ 11.49 $ —
Summary of Stock Options Summarized by Exercise Price	Information relating to outstanding stock options at September 30, 2015 summarized by exercise price is as follows: Outstanding Weighted Average Exercisable Weighted Exercise Price Per Share Shares Remaining Exercise Shares Exercise Performance Incentive Stock Option Plan: $11.49 98,410 27 $ 11.49 — $ — 98,410 $ 11.49 — $ —
Weighted Average Exercise Prices for Options Granted and Exercisable and Weighted Average Remaining Contractual Life for Options Outstanding	The weighted average exercise prices for options granted and exercisable and the weighted average remaining contractual life for options outstanding as of September 30, 2015 are as follows: Number Weighted Weighted Intrinsic As of September 30, 2015: Incentive Stock Option Plans: Outstanding 98,410 $ 11.49 27 $ 7 Expected to Vest 54,692 $ 11.49 27 $ 4 Exercisable — $ — — $ —
Restricted Stock
Summary of Non-Vested Shares	Restricted Shares — Nine Months Ended September 30, 2015 Nine Months Ended September 30, 2014 Number Weighted Number Weighted Nonvested shares at January 1 st 560,842 $ 21.44 376,702 $ 24.85 Granted 30,000 11.42 — — Vested (192,266 ) 20.47 (1,000 ) 31.83 Forfeited (422 ) 14.92 (1,840 ) 24.23 Nonvested shares at March 31 st 398,154 $ 21.17 373,862 $ 24.83 Granted 21,005 14.28 240,724 14.81 Vested (28,505 ) 13.53 (23,478 ) 13.84 Forfeited (1,201 ) 14.92 — — Nonvested shares at June 30 th 389,453 $ 21.37 591,108 $ 21.19 Granted 13,196 12.88 — — Vested (19,000 ) 27.93 (4,000 ) 12.16 Forfeited (26,723 ) 22.64 (6,104 ) 14.92 Nonvested shares at September 30 th 356,926 $ 20.62 581,004 $ 21.32
Performance Based Restricted Stock
Summary of Non-Vested Shares	Performance Based Shares — Nine Months Ended September 30, 2015 Nine Months Ended September 30, 2014 Number Weighted Number Weighted Date Fair Nonvested shares at January 1 st 103,907 $ 17.77 24,637 $ 28.28 Granted 7,500 10.96 — — Nonvested shares at March 31 st 111,407 $ 17.31 24,637 $ 28.28 Granted — — 79,270 14.51 Nonvested shares at June 30 th 111,407 $ 17.31 103,907 $ 17.77 Granted 3,196 12.37 — — Forfeited (10,200 ) 18.43 — — Nonvested shares at September 30 th 104,403 $ 17.05 103,907 $ 17.77

Accumulated Other Comprehensi33

Accumulated Other Comprehensive Income ("AOCI") (Tables)	9 Months Ended
	Sep. 30, 2015
Beginning Balance, Annual Activity and Ending Balance of Accumulated Other Comprehensive Loss of of Foreign Currency Translation Adjustments	The following table lists the beginning balance, annual activity and ending balance of accumulated other comprehensive loss, which consists of foreign currency translation adjustments: Balance, December 31, 2014 $ (1,970 ) Other comprehensive loss (248 ) Balance, March 31, 2015 $ (2,218 ) Other comprehensive loss (323 ) Balance, June 30, 2015 $ (2,541 ) Other comprehensive loss (897 ) Balance, September 30, 2015 $ (3,438 )

Summary of Property, Plant and

Summary of Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	$ 138,099	$ 133,241
Less accumulated depreciation	(89,639)	(83,215)
Total Property, plant and equipment	48,460	50,026
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	2,458	2,458
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	14,419	14,380
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	109,223	107,899
Office furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	4,957	4,698
Automotive equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	491	374
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, Gross	$ 6,551	$ 3,432

Property, Plant and Equipment -

Property, Plant and Equipment - Additional Information (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2015USD ($)
Property, Plant and Equipment [Line Items]
Elimination of Assets and Accumulated depreciation	$ 338

Components of Inventories (Deta

Components of Inventories (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Inventory [Line Items]
Finished products	$ 128,788	$ 142,853
Raw materials	32,708	22,778
Total Inventories	$ 161,496	$ 165,631

Segment Reporting - Additional

Segment Reporting - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2015Segment
Number of reportable business segments	1

Summary of Business Sales Segme

Summary of Business Sales Segmentation as per Product (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Net Sales:
Total crop	$ 63,641	$ 64,700	$ 180,954	$ 195,254
Non-crop	8,845	6,935	24,620	25,789
Net sales	72,486	71,635	205,574	221,043
Insecticides
Net Sales:
Total crop	23,539	24,626	85,484	105,587
Herbicides/Soil Fumigants/Fungicides
Net Sales:
Total crop	32,682	29,363	71,973	66,220
Other, Including Plant Growth Regulators
Net Sales:
Total crop	$ 7,420	$ 10,711	$ 23,497	$ 23,447

Summary of Business Sales Seg39

Summary of Business Sales Segmentation as per Location (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Net Sales:
Net sales	$ 72,486	$ 71,635	$ 205,574	$ 221,043
US
Net Sales:
Net sales	53,167	54,552	146,231	162,602
International
Net Sales:
Net sales	$ 19,319	$ 17,083	$ 59,343	$ 58,441

Cash Dividends (Detail)

Cash Dividends (Detail) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2015USD ($)$ / shares
Dividends [Line Items]
Cash dividend declaration date	Mar. 16, 2015
Cash dividend distributed date	Apr. 17, 2015
Cash dividend record date	Apr. 3, 2015
Cash dividend per share | $ / shares	$ 0.02
Cash dividends paid	$ 572

Cash Dividends - Additional Inf

Cash Dividends - Additional Information (Detail) - USD ($) $ in Thousands	Jan. 09, 2015	Sep. 30, 2015	Sep. 30, 2014
Dividends Payable [Line Items]
Payment of cash dividends	$ 569	$ 1,141	$ 4,251

Components of Basic and Diluted

Components of Basic and Diluted Earnings Per Share (Detail) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Numerator:
Net income attributable to AVD	$ 2,772	$ 732	$ 3,604	$ 3,036
Denominator:
Weighted average shares outstanding-basic	28,753	28,466	28,653	28,422
Dilutive effect of stock options and grants	536	331	555	466
Weighted average shares outstanding-assuming dilution	29,289	28,797	29,208	28,888

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Components Of Basic And Diluted Earning Per Share [Line Items]
Anti-dilutive stock options excluded from computation of diluted earning per share	0	1,207	0	6,183

Summary Revolving Line of Credi

Summary Revolving Line of Credit And Various Notes Payable Constitute Short-Term and Long-Term Loan Balances Together (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Extinguishment of Debt [Line Items]
Indebtedness, Long-term	$ 82,658	$ 98,605
Indebtedness, Short-term	10,073	71
Total indebtedness	92,731	98,676
Revolving Line of Credit
Extinguishment of Debt [Line Items]
Indebtedness, Long-term	83,400	99,400
Total indebtedness	83,400	99,400
Deferred Loan Fees
Extinguishment of Debt [Line Items]
Indebtedness, Long-term	(742)	(850)
Total indebtedness	(742)	(850)
Notes payable
Extinguishment of Debt [Line Items]
Indebtedness, Long-term		55
Indebtedness, Short-term	10,073	71
Total indebtedness	$ 10,073	$ 126

Indebtedness - Additional Infor

Indebtedness - Additional Information (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Debt Instrument [Line Items]
Available borrowings capacity under credit agreement		$ 51,156,000
Senior secured credit facility term	5 years
Duration of losses in other comprehensive income expected to be reclassified to earnings	12 months
Maximum
Debt Instrument [Line Items]
Capacity to increase borrowings under credit agreement	$ 40,189,000
Term Loan | Maximum
Debt Instrument [Line Items]
Accordion feature	100,000,000
Revolving Line of Credit
Debt Instrument [Line Items]
Available borrowings capacity under credit agreement	200,000,000
Cash Flow Hedging | Interest Rate Swap
Debt Instrument [Line Items]
Gains (losses) in other comprehensive income expected to be reclassified to earnings	$ 0

Summary of Effect of Derivative

Summary of Effect of Derivative Instruments on Statements of Operations and Comprehensive Income (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)		$ (1)		$ (32)
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)		(146)		(459)
Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)	$ 0	0	$ 0	0
Designated as Hedging | Cash Flow Hedging | Interest Rate Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)		(1)		(32)
Designated as Hedging | Cash Flow Hedging | Interest Rate Contracts | Interest Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)		(146)		(459)
Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)	$ 0	$ 0	$ 0	$ 0

Stock Based Compensation, Unamo

Stock Based Compensation, Unamortized Stock-Based Compensation and Remaining Weighted Average Period (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 458	$ 1,240	$ 2,943	$ 3,046
Unamortized Stock-Based Compensation	4,819	7,473	4,819	7,473
Performance Based Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	12		100
Unamortized Stock-Based Compensation	373		$ 373
Remaining Weighted Average Period (years)			2 years 2 months 12 days
Incentive Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	94	0	$ 325	21
Unamortized Stock-Based Compensation	1,009		$ 1,009
Remaining Weighted Average Period (years)			2 years 3 months 18 days
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	334	1,139	$ 2,296	2,958
Unamortized Stock-Based Compensation	2,751	6,069	$ 2,751	$ 6,069
Remaining Weighted Average Period (years)			1 year 6 months	1 year 10 months 24 days
Performance Based Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	18	101	$ 222	$ 67
Unamortized Stock-Based Compensation	$ 686	$ 1,404	$ 686	$ 1,404
Remaining Weighted Average Period (years)			1 year 9 months 18 days	2 years 4 months 24 days

Stock Based Compensation Expens

Stock Based Compensation Expense - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employees options granted							0
Stock-based compensation	$ 458			$ 1,240			$ 2,943	$ 3,046
Common stock, shares issued	31,623,810						31,623,810		31,550,477
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 334			$ 1,139			$ 2,296	$ 2,958
Nonvested unamortized stock-based compensation, contractual term							1 year 6 months	1 year 10 months 24 days
Number of Shares, Granted	13,196	21,005	30,000		240,724		64,201	240,724
Number of Shares, Vested	19,000	28,505	192,266	4,000	23,478	1,000		23,478
Number of years of service before cliff vesting							3 years	3 years
Weighted Average Grant-Date Fair Value, Granted	$ 12.88	$ 14.28	$ 11.42		$ 14.81		$ 12.66	$ 14.81
Nonvested unamortized stock-based compensation other than options, value	$ 2,751			$ 6,069			$ 2,751	$ 6,069
Restricted Stock | Vested immediately
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Vested							21,005
Restricted Stock | Vest after 90 days
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Vested							7,500
Restricted Stock | Vest one-third each year
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Vested							3,196
Performance Based Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 18			101			$ 222	$ 67
Nonvested unamortized stock-based compensation, contractual term							1 year 9 months 18 days	2 years 4 months 24 days
Number of Shares, Granted	3,196		7,500		79,270		10,696	79,270
Weighted Average Grant-Date Fair Value, Granted	$ 12.37		$ 10.96		$ 14.51
Nonvested unamortized stock-based compensation other than options, value	$ 686			$ 1,404			$ 686	$ 1,404
Cliff vesting date								May 23, 2017
Targeted performance percentage	200.00%			200.00%			200.00%	200.00%
Performance Based Restricted Stock | Performance Based Shares Based Upon Financial Performance of Earnings before Interest Tax ("EBIT") and Net Sales Goal for the Period Commencing January 1, 2015 and Ending December 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares vesting based on Performance							80.00%	80.00%
Earnings before income tax goal weight, percentage							50.00%	50.00%
Net sales goal weight, percentage							30.00%	30.00%
Performance Based Restricted Stock | Performance Based Shares Based Upon AVD Stock Price Appreciation Over the Course of the Period Commencing January 1, 2015, Ending December 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares vesting based on Performance							20.00%	20.00%
Performance Based Restricted Stock | Vest on January 5, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Granted							7,500
Cliff vesting date							Jan. 5, 2018
Performance Based Restricted Stock | Vest on August 1, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Granted							3,196
Cliff vesting date							Aug. 1, 2018
Performance Based Restricted Stock | Performance Based Shares Related to Net Income Weighted at 50%, Net Sales Weighted at 30%, Commencing January 1, 2015 and Ending December 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant-Date Fair Value, Granted							$ 11.86
Performance Based Restricted Stock | Remaining 20% of Performance Based Shares are Based Upon AVD Stock Price Appreciation for the Period Commencing January 1, 2015 and Ending December 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant-Date Fair Value, Granted							$ 9.48
Incentive Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 94			$ 0			$ 325	$ 21
Nonvested unamortized stock-based compensation, value	1,009						$ 1,009
Nonvested unamortized stock-based compensation, contractual term							2 years 3 months 18 days
Performance Based Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	12						$ 100
Nonvested unamortized stock-based compensation, value	$ 373						$ 373
Nonvested unamortized stock-based compensation, contractual term							2 years 2 months 12 days
Common stock, shares issued									0

Summary of Option Activity (Det

Summary of Option Activity (Detail) - $ / shares	3 Months Ended			9 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Sep. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incentive Stock Option Plans, Beginning balance	660,573	697,854	724,904	724,904
Incentive Stock Option Plans, Option exercised	(4,000)	(34,800)	(16,650)
Incentive Stock Option Plans, Option forfeited	(22,582)	(2,481)	(10,400)
Incentive Stock Option Plans, Ending balance	633,991	660,573	697,854	633,991
Weighted Average Price Per Share, Beginning balance	$ 9.29	$ 9.21	$ 9.22	$ 9.22
Weighted Average Price Per Share, Option exercised	7.50	7.50	7.50
Weighted Average Price Per Share, Option forfeited	11.49	11.49	11.49
Weighted Average Price Per Share, Ending balance	9.25	9.29	9.21	9.25
Exercisable Weighted Average Price Per Share, Beginning balance	7.72	7.71	7.82	7.82
Exercisable Weighted Average Price Per Share, Ending balance	$ 7.73	$ 7.72	$ 7.71	$ 7.73
Performance Based Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incentive Stock Option Plans, Beginning balance			107,689	107,689
Incentive Stock Option Plans, Option forfeited				(9,279)
Incentive Stock Option Plans, Ending balance	98,410			98,410
Weighted Average Price Per Share, Beginning balance			$ 11.49	$ 11.49
Weighted Average Price Per Share, Option forfeited				11.49
Weighted Average Price Per Share, Ending balance	$ 11.49			$ 11.49

Summary of Option Activity (Par

Summary of Option Activity (Parenthetical) (Detail) - $ / shares	3 Months Ended			9 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Sep. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Price Per Share, Option exercised	$ 7.50	$ 7.50	$ 7.50
Weighted Average Price Per Share, Option forfeited	$ 11.49	$ 11.49	11.49
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Price Per Share, Option forfeited			11.49
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Price Per Share, Option forfeited			$ 13.24
Performance Based Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Price Per Share, Option forfeited				$ 11.49

Summary of Stock Options Summar

Summary of Stock Options Summarized by Exercise Price (Detail) - $ / shares	9 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Weighted Average, Exercise Price	$ 9.25	$ 9.29	$ 9.21	$ 9.22
Exercisable Weighted Average, Exercise Price	$ 7.73	$ 7.72	$ 7.71	7.82
Performance Based Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Weighted Average, Shares	98,410
Outstanding Weighted Average, Remaining Life (Months)	27 months
Outstanding Weighted Average, Exercise Price	$ 11.49			$ 11.49
Performance Based Options | Range Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price Per Share, Lower Range	$ 11.49
Outstanding Weighted Average, Shares	98,410
Outstanding Weighted Average, Remaining Life (Months)	27 months
Outstanding Weighted Average, Exercise Price	$ 11.49
Incentive Stock Option Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Weighted Average, Shares	633,991
Outstanding Weighted Average, Remaining Life (Months)	82 months
Outstanding Weighted Average, Exercise Price	$ 9.25
Exercisable Weighted Average, Shares	378,429
Exercisable Weighted Average, Exercise Price	$ 7.73
Incentive Stock Option Plan | Range One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price Per Share, Lower Range	$ 7.50
Outstanding Weighted Average, Shares	361,750
Outstanding Weighted Average, Remaining Life (Months)	62 months
Outstanding Weighted Average, Exercise Price	$ 7.50
Exercisable Weighted Average, Shares	361,750
Exercisable Weighted Average, Exercise Price	$ 7.50
Incentive Stock Option Plan | Range Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price Per Share, Lower Range	$ 11.32
Outstanding Weighted Average, Shares	272,241
Exercise Price Per Share, Upper Range	$ 11.49
Outstanding Weighted Average, Remaining Life (Months)	107 months
Outstanding Weighted Average, Exercise Price	$ 11.56
Exercisable Weighted Average, Shares	16,679
Exercisable Weighted Average, Exercise Price	$ 12.69

Weighted Average Exercise Price

Weighted Average Exercise Prices for Options Granted and Exercisable and Weighted Average Remaining Contractual Life for Options Outstanding (Detail) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Outstanding	633,991	660,573	697,854	724,904
Weighted Average Exercise Price, Outstanding	$ 9.25	$ 9.29	$ 9.21	$ 9.22
Weighted Average Exercisable, Exercise Price	$ 7.73	$ 7.72	$ 7.71	$ 7.82
Incentive Stock Option Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Outstanding	633,991
Number of Shares, Expected to Vest	623,148
Number of Shares, Exercisable	378,429
Weighted Average Exercise Price, Outstanding	$ 9.25
Weighted Average Exercise Price, Expected to Vest	9.21
Weighted Average Exercisable, Exercise Price	$ 7.73
Weighted Average Remaining Life, Outstanding	82 months
Weighted Average Remaining Contractual Life, Expected to Vest	81 months
Weighted Average Remaining Contractual Life, Exercisable	62 months
Intrinsic Value, Outstanding	$ 1,489
Intrinsic Value, Expected to Vest	1,488
Intrinsic Value, Exercisable	1,471
Intrinsic Value, Outstanding	1,489
Intrinsic Value, Expected to Vest	1,488
Intrinsic Value, Exercisable	$ 1,471
Performance Based Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Outstanding	98,410			107,689
Number of Shares, Expected to Vest	54,692
Weighted Average Exercise Price, Outstanding	$ 11.49			$ 11.49
Weighted Average Exercise Price, Expected to Vest	$ 11.49
Weighted Average Remaining Life, Outstanding	27 months
Weighted Average Remaining Contractual Life, Expected to Vest	27 months
Intrinsic Value, Outstanding	$ 7
Intrinsic Value, Expected to Vest	4
Intrinsic Value, Outstanding	7
Intrinsic Value, Expected to Vest	$ 4

Summary of Non-Vested Shares (D

Summary of Non-Vested Shares (Detail) - Restricted Stock - $ / shares	3 Months Ended						9 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Sep. 30, 2015	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Beginning balance	389,453	398,154	560,842	591,108	373,862	376,702	560,842	376,702
Number of Shares, Granted	13,196	21,005	30,000		240,724		64,201	240,724
Number of Shares, Vested	(19,000)	(28,505)	(192,266)	(4,000)	(23,478)	(1,000)		(23,478)
Number of Shares, Forfeited	(26,723)	(1,201)	(422)	(6,104)		(1,840)
Number of Shares, Ending Balance	356,926	389,453	398,154	581,004	591,108	373,862	356,926	581,004
Weighted Average Grant-Date Fair Value, Beginning balance	$ 21.37	$ 21.17	$ 21.44	$ 21.19	$ 24.83	$ 24.85	$ 21.44	$ 24.85
Weighted Average Grant-Date Fair Value, Granted	12.88	14.28	11.42		14.81		12.66	14.81
Weighted Average Grant-Date Fair Value, Vested	27.93	13.53	20.47	12.16	13.84	31.83
Weighted Average Grant-Date Fair Value, Forfeited	22.64	14.92	14.92	14.92		24.23
Weighted Average Grant-Date Fair Value, Ending balance	$ 20.62	$ 21.37	$ 21.17	$ 21.32	$ 21.19	$ 24.83	$ 20.62	$ 21.32

Status Summary of Non-Vested Sh

Status Summary of Non-Vested Shares (Detail) - Performance Based Restricted Stock - $ / shares	3 Months Ended						9 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Sep. 30, 2015	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Beginning balance	111,407	111,407	103,907	103,907	24,637	24,637	103,907	24,637
Number of Shares, Granted	3,196		7,500		79,270		10,696	79,270
Number of Shares, Forfeited	(10,200)
Number of Shares, Ending Balance	104,403	111,407	111,407	103,907	103,907	24,637	104,403	103,907
Weighted Average Grant-Date Fair Value, Beginning balance	$ 17.31	$ 17.31	$ 17.77	$ 17.77	$ 28.28	$ 28.28	$ 17.77	$ 28.28
Weighted Average Grant-Date Fair Value, Granted	12.37		10.96		14.51
Weighted Average Grant-Date Fair Value, Forfeited	18.43
Weighted Average Grant-Date Fair Value, Ending balance	$ 17.05	$ 17.31	$ 17.31	$ 17.77	$ 17.77	$ 28.28	$ 17.05	$ 17.77

Legal Proceedings - Additional

Legal Proceedings - Additional Information (Detail) $ in Thousands	May. 13, 2015USD ($)	Apr. 14, 2014PlaintiffDefendant	Aug. 21, 2012Case	May. 31, 2012CasePerson	Sep. 30, 2015
Sanchez v. Agro Logistic Systems, Inc et al
Loss Contingencies [Line Items]
Number of claimants | Plaintiff		2
Number of defendants | Defendant		27
Case dismissal period					90 days
Louisiana | HendlerLaw, P.C. | U.S. State District Court
Loss Contingencies [Line Items]
Number of lawsuits filed				7
Delaware
Loss Contingencies [Line Items]
Number of lawsuits filed				9
Delaware | U.S. State District Court
Loss Contingencies [Line Items]
Number of lawsuits filed				8
Legal proceedings number of personal injuries				6
Number of claimants | Person				235
Number of dismissed complaints			6
Delaware | Superior Court
Loss Contingencies [Line Items]
Number of lawsuits filed				1
USEPA TSCA Matter
Loss Contingencies [Line Items]
Settlement amount | $	$ 82

Beginning Balance, Annual Activ

Beginning Balance, Annual Activity and Ending Balance of Accumulated Other Comprehensive Income (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive loss	$ (897)	$ (323)	$ (248)
Balance, September 30, 2015	$ (3,438)	$ (2,541)	$ (2,218)

Equity Investment - Additional

Equity Investment - Additional Information (Detail) £ in Thousands, $ in Thousands	Mar. 25, 2013USD ($)	Oct. 31, 2014USD ($)shares	Jul. 31, 2014USD ($)shares	Jul. 31, 2014GBP (£)shares	Feb. 28, 2014USD ($)shares	Feb. 28, 2014GBP (£)shares	Sep. 30, 2015USD ($)	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)
Equity Method Investments [Line Items]
Equity investment	$ 3,687
Gain on dilution of equity method investment									$ 954
Equity investment ownership position	29.27%						21.18%	21.18%
Loss from equity method investment							$ (389)	$ (580)	$ (633)
Warrants exercised amount		$ 500
Warrants exercised shares | shares		6,155,000
Carrying value of equity investment							2,592	2,592
Quoted market value of equity investment							$ 3,999	$ 3,999
TyraTech Inc.
Equity Method Investments [Line Items]
Shares issued by equity investee | shares			50,000,000	50,000,000	37,391,763	37,391,763
Amount raised by equity investee on shares issued			$ 5,900	£ 3,500	$ 3,100	£ 1,870

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Taxes [Line Items]
Income taxes expense	$ 1,643	$ 0	$ 958	$ 856
Effective tax rate			19.00%	21.00%